SamaCare, a specialty medication workflow platform, has secured $17 million in a Series B investment round led by Questa Capital, with existing investors participating. The California-based company offers a cloud-based platform to streamline the process of obtaining prior authorization for specialty drugs and verifying benefits. The funds will be used to enhance their Script-to-Therapy Operating System with AI capabilities, data insights, and collaboration features. SamaCare’s goal is to help patients, providers, and pharmaceutical companies overcome administrative and financial obstacles to access treatments. Other companies in the market offering similar platforms include Cerner and Epic, which focus on clinical and administrative workflows.
Source link
SamaCare garners $17M for its specialty medication workflow platform
